This site is intended for Healthcare Professionals only.

MHRA issues class 4 drug alert for Memantine 10 mg tablets


Share post:

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a class 4 pharmacy level caution in use for Memantine 10mg Film-Coated Tablets.

Crescent Pharma Ltd has informed the government agency of a discrepancy on the product packaging for three batches. The discrepancy relates to the incorrect quantity printed on one side (end flap) of the packs in error.

“The incorrect end flap states that the quantity of tablets within the pack is 30, however, this is incorrect and should state 28 as per all other sides of the pack. The other product details on the pack including the name, strength and pharmaceutical form of the medicine are correct,” an official statement read.

Pharmacists are advised to exercise caution when dispensing the product. There is no risk to product quality as a result of this issue, therefore the associated batches are not being recalled at this time.

Product details:

Batch Number Expiry Date Pack Size
10819 08/2022 28
20819 08/2022 28
11119 11/2022 28


Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Collaboration and partnership: The way forward with community pharmacy

Professor Mahendra G Patel elucidates how pharmacy professionals working in the multidisciplinary team can help to improve the...

Sigma Conference 2024: Sector says Pharmacy First won’t solve funding crisis

Demands for the next contractual framework include additional funding and write-off of any money that is owed, among...

Demand for private health cover surge amid NHS waiting list crisis

The UK health cover market was valued at £6.7 billion in 2022, marking a £385 million increase from...

Key Facts To Know Before Having a Blepharoplasty

It is very much a cultural thing. In Korea, having hooded eyes is seen as a sign of extreme...